Chill out to burn fat? scientists probe brown Fat's secrets
NCT ID NCT07048405
First seen Jun 27, 2026 · Last updated Jul 01, 2026 · Updated 2 times
Summary
This study looks at how repeated short-term cold exposure affects brown adipose tissue (brown fat), a type of body fat that burns energy to generate heat. Twelve healthy adults will undergo a 10-day cold acclimation protocol using cooling blankets. Researchers will take tissue samples and use PET/CT scans to measure changes in brown fat activity and gene expression, aiming to better understand its role in metabolism.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could reveal how cold exposure improves metabolism, potentially pointing toward new ways to manage weight or metabolic health.
- What could go wrong
- This is a very small, early-stage study (12 people) focused on understanding basic biology, not testing a treatment. Results may not apply to the general population.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 12 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
May 2025
- Expected to finish
-
Jul 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 40 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Aged 18-40 years * Body mass index 18.5-25 kg/m2 * Weight change of less than 5% in the past 6 months * No acute or chronic medical conditions * On no regular medications (other than contraceptives in female participants) * No claustrophobia * Alcohol intake ≤14 units/ week * Screening blood tests within acceptable limits (of no clinical significance) * Not currently pregnant, lactating or breastfeeding (female participants only) * Ability to provide informed consent. Exclusion Criteria: * Not meeting inclusion criteria * Contra-indication to PET/CT scan * Allergy to local anaesthetic
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for 18F-FDG pet/CT are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Royal Infirmary of Edinburgh
RECRUITINGEdinburgh, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could cold climates shape heart healing after stents?
- Could a winter dip boost your blood? scientists investigate
- Brown fat may hold key to weight loss drug response
- Fish oil might keep you warmer in the cold, study suggests
- Chilly vests reveal hidden fat secrets that could fight obesity
- Chilling out to fight cancer: cold therapy meets immunotherapy in new trial